Pharmaceutical manufacturing quality experts are essential professionals who ensure that every drug produced adheres to strict quality standards and regulatory requirements. Their responsibilities include overseeing the entire manufacturing process, from raw material inspection to final product release, to guarantee that medications are safe, effective, and consistent. These experts implement and monitor compliance with Good Manufacturing Practices (GMP), conduct thorough quality control testing, and validate production processes. By identifying and addressing deviations, contamination risks, or batch inconsistencies early on, they help prevent costly recalls and protect patient health. Their vigilance is crucial in maintaining the trust of regulatory bodies and consumers alike.
In addition to regulatory compliance, pharmaceutical manufacturing quality experts play a vital role in continuous process improvement. They analyze production data to detect trends and potential issues, developing corrective and preventive actions (CAPA) to enhance product quality and manufacturing efficiency. Collaboration with research and development, production teams, and regulatory affairs is key to integrating new technologies and innovations without compromising quality. With the increasing complexity of drug formulations and manufacturing methods, these experts are also pivotal in managing risk assessments and ensuring robust documentation throughout the production lifecycle. Ultimately, pharmaceutical manufacturing quality experts uphold the standards that enable safe, reliable medicines to reach patients worldwide.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada